Katrine Prier Lindvig focus her research on non-invasive diagnostic markers and early diagnosis and prognosis of chronic fatty liver disease within the primary health care setting. Specifically, is development of intelligent algorithms to exploit knowledge and data in a better way, a top priority to Katrine. Furthermore, she is working with regulatory aspects regarding CE and FDA approvals of new medical devices and pharmacological therapies. Katrine Prier Lindvig also does ultrasound examinations, elastography and liver biopsies.